Publié dans Therapies.

THERAPIES - SOMMAIRE MARS AVRIL 2023

Le Vol 78 - N°2 - MARS AVRIL 2023 est en ligne
 
Au sommaire

SPECIAL ISSUE
 
WOMEN AND PHARMACOLOGY: DRUGS AND GENDER
 
 
Women, medicine and pharmacology: Where do we are now
Maryse Lapeyre-Mestre
 
·Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project
Evelina Cardoso, Anaëlle Monfort, Ema Ferreira, Hedvig Nordeng, Ursula Winterfeld, Karel Allegaert, Peggy Gandia, Monia Guidi, Alice Panchaud
 
·Addictovigilance in women, the hidden part of the iceberg?
Maryse Lapeyre-Mestre
 
·Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?
Maylis Balon, Samuel Tessier, Christine Damase-Michel, Judith Cottin, Aude Lambert, Marie-Andrée Thompson, Justine Benevent, Isabelle Lacroix
 
·Sex differences in adverse drug reactions: Are women more impacted?
Clémence Lacroix, Anaïs Maurier, Bérenger Largeau, Alexandre Destere, Eve-Marie Thillard, Milou Drici, Joëlle Micallef, Annie Pierre Jonville-Bera
 
·Sex differences: From preclinical pharmacology to clinical pharmacology
Romain Barus, Sandrine Bergeron, Yaohua Chen, Sophie Gautier
 
·Les différences entre les sexes : de la pharmacologie préclinique à la pharmacologie clinique
Romain Barus, Sandrine Bergeron, Yaohua Chen, Sophie Gautier
 
·Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey
Léna Blayac, Camille Ponte, Monique Lavaud, Joëlle Micallef, Maryse Lapeyre-Mestre
 
·Systematic review on sex differences for drug use after stroke
Julia Perrier, Mathilde Renard, Antoine Pariente, Julien Bezin